Cutaneous granulomas during infliximab therapy for spondyloarthropathy.
Dubosc
Andra Economu
AE
Perroud
Anne-Marie
AM
Bagot
Martine
M
Farenq
Valérie
V
Chevalier
Xavier
X
Maitre
Bernard
B
Claudepierre
Pascal
P
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006099:Granuloma / Q000150:complications / Q000209:etiology*; D006801:Humans; D000069285:Infliximab; D017563:Lung Diseases, Interstitial / Q000150:complications / Q000209:etiology; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000209:etiology; D012871:Skin Diseases / Q000150:complications / Q000209:etiology*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab